ArticleOphthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)2026
A Quantitative Evaluation of the PowerRef 3 for Measuring Gaze Position.
Article in Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo evaluate the quality of gaze position measurements from the PowerRef 3 photorefractor and assess the impact of gaze position on the PowerRef 3 refractive measurements.
methodsMonocular right-eye gaze was recorded in 20 adults (16 female, 4 male; 25.0±7.4 years) using the PowerRef 3 photorefractor (50 Hz). Participants fixated a target at 120 cm in 39 randomised locations (±24° horizontally [h], ±14° vertically [v]; 2° steps from centre). At each location, spatial accuracy, precision (root mean square of distances between samples and mean fixation [RMS-mean] and between successive samples [RMS-S2S]) and data loss were assessed. The impact of gaze position on refractive measurements was also examined. Gaze position data were also recorded using the EyeLink 1000 (500 Hz) to provide reference quality metrics.
resultsThe PowerRef 3 had spatial accuracy of h = 1.45° ± 0.41° and v = 1.29° ± 0.15° and variable precision (RMS-Mean: h = 1.37° ± 0.12°, v = 1.32° ± 0.11°; RMS-S2S: h = 1.96° ± 0.16°, v = 1.90° ± 0.18°). Reference metrics obtained using the EyeLink showed slightly higher accuracy and precision (accuracy: h = 0.53° ± 0.09°, v = 0.52° ± 0.09°; RMS-Mean: h = 0.17° ± 0.02°, v = 0.19° ± 0.03°; RMS-S2S: h = 0.08° ± 0.01°, v = 0.07° ± 0.01°). Notable data loss for the PowerRef 3 was primarily observed at eccentric horizontal locations (0°-±16°: ≤30% of participants; ±20°-±24°: 35-70%; EyeLink 0°-±24°: ≤5%). PowerRef 3 data loss was also greater for lower vertical targets (≥30%) than for higher ones (≤20%). Relative to the pupillary axis, refractive measurements were more hyperopic beyond +10° horizontally (rightward gaze; 0.36-0.62 D) and beyond -6° vertically (downward; 0.59-1.44 D) and more myopic (≤1.29 D) between -10° to -18° horizontally (leftward).
conclusionThe PowerRef 3 can record gaze positions within ±8° horizontally and -4° (downward) to +10° (upward) vertically without a significant impact on both gaze and refractive measurements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.